Characteristics of Pivotal Trials and FDA Review of Innovative Devices

PLoS ONE - United States
doi 10.1371/journal.pone.0117235
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Pmu72 - Estimated Costs of Pivotal Trials for Novel Therapeutic Agents Approved by the Fda, 2015-2016

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

FDA Oversight of Cell Therapy Clinical Trials

Science Translational Medicine
Medicine
2012English

Benefits and Harms in Pivotal Trials of Oral Centrally Acting Antiobesity Medicines: A Systematic Review and Meta-Analysis

Obesity
NutritionEndocrinologyDieteticsMedicineMetabolismDiabetes
2018English

On Statistical Principles for Clinical Trials in Pharmaceutical Development-A Review of China FDA Draft Guidance

Pharmaceutical Regulatory Affairs: Open Access
2015English

Review of Acute Treatment of Migraine Trial Results With the New FDA Endpoints: Design Implications for Future Trials

Headache
Neurology
2019English

Identifying Differential Responders and Their Characteristics in Clinical Trials: Innovative Methods for Analyzing Longitudinal Data

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

From the FDA: Approval of Medical Devices to Be Accelerated

Journal of the American Osteopathic Association, The
MedicineAlternative MedicineComplementary
1995English

Topological Insulators and Superconductors for Innovative Devices

2015English

Characteristics of Oncology Clinical Trials

JAMA Internal Medicine
Internal Medicine
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy